Adherence to clinical practice guidelines and outcomes in diabetic patients.
暂无分享,去创建一个
H. Chin | S. Oh | S.-W. Oh | H. J. Lee | H. J. Chin | J.-I. Hwang | Jee-In Hwang | H. Lee | Ha Jeong Lee
[1] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[2] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[3] M. Dennis. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .
[4] R. Klein. Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes , 1995, Diabetes Care.
[5] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[6] K. Choi,et al. Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. , 2006, Diabetes care.
[7] P. Winocour. Effective diabetes care: a need for realistic targets , 2002, BMJ : British Medical Journal.
[8] K. Khunti,et al. Quality of care of patients with diabetes: collation of data from multi-practice audits of diabetes in primary care. , 1999, Family practice.
[9] G. Kelton,et al. Utilization of health care quality markers in a family medicine outpatient setting. , 2006, Family medicine.
[10] Weiping Jia,et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.
[11] Walker,et al. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .
[12] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[13] D. Clement. A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .
[14] M. Chin,et al. Quality of diabetes care in community health centers. , 2000, American journal of public health.
[15] Opinions of Japanese rheumatology physicians regarding clinical practice guidelines. , 2010, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[16] G. Costa,et al. Determinants of Quality in Diabetes Care Process , 2009, Diabetes Care.
[17] P. Bovier,et al. Adherence to recommended standards of diabetes care by Swiss primary care physicians. , 2007, Swiss medical weekly.
[18] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[19] David Roth,et al. A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .
[20] Sarah J. Beaton,et al. Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. , 2004, Diabetes care.